Meeder Asset Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.5K Buy
557
+423
+316% +$37.7K ﹤0.01% 455
2025
Q4
$10.6K Sell
134
-4
-3% -$314 ﹤0.01% 648
2025
Q3
$11K Buy
138
+8
+6% +$682 ﹤0.01% 531
2025
Q2
$11.8K Buy
130
+23
+21% +$2.1K ﹤0.01% 586
2025
Q1
$10K Sell
107
-54
-34% -$4.83K ﹤0.01% 646
2024
Q4
$14.6K Sell
161
-15
-9% -$1.43K ﹤0.01% 611
2024
Q3
$18.3K Buy
176
+12
+7% +$1.22K ﹤0.01% 518
2024
Q2
$15.9K Buy
164
+20
+14% +$1.84K ﹤0.01% 561
2024
Q1
$13K Buy
+144
New +$12.2K ﹤0.01% 510
2022
Q4
Sell
-10,045
Closed -$706K 1008
2022
Q3
$706K Buy
10,045
+259
+3% +$20.3K 0.04% 316
2022
Q2
$784K Buy
9,786
+918
+10% +$71.8K 0.05% 307
2022
Q1
$672K Buy
+8,868
New +$702K 0.03% 343
2021
Q4
Sell
-6,900
Closed -$521K 1375
2021
Q3
$521K Sell
6,900
-29
-0.4% -$2.3K 0.03% 418
2021
Q2
$564K Buy
6,929
+1,659
+31% +$136K 0.03% 446
2021
Q1
$415K Sell
5,270
-1,966
-27% -$154K 0.02% 544
2020
Q4
$619K Buy
7,236
+1,203
+20% +$99.5K 0.14% 131
2020
Q3
$465K Buy
6,033
+523
+9% +$39.9K 0.03% 379
2020
Q2
$404K Buy
5,510
+329
+6% +$23.4K 0.03% 422
2020
Q1
$344K Buy
5,181
+2,926
+130% +$206K 0.03% 431
2019
Q4
$155K Buy
2,255
+512
+29% +$34.9K 0.01% 667
2019
Q3
$128K Buy
1,743
+323
+23% +$23.4K 0.01% 733
2019
Q2
$102K Buy
1,420
+1,373
+2,921% +$97.5K 0.01% 752
2019
Q1
$3K Buy
+47
New +$3.04K ﹤0.01% 1485
2018
Q3
Sell
-1,110
Closed -$71.9K 1560
2018
Q2
$71.9K Buy
+1,110
New +$72.6K 0.01% 687
2018
Q1
Sell
-60,385
Closed -$4.56M 1588
2017
Q4
$4.56M Buy
60,385
+58,040
+2,475% +$4.24M 0.39% 64
2017
Q3
$171K Buy
+2,345
New +$169K 0.02% 493
2016
Q3
Sell
-14,870
Closed -$1.09M 778
2016
Q2
$1.09M Buy
14,870
+2,035
+16% +$145K 0.1% 212
2016
Q1
$907K Buy
12,835
+1,295
+11% +$86.2K 0.09% 234
2015
Q4
$769K Sell
11,540
-8,136
-41% -$541K 0.07% 227
2015
Q3
$1.25M Buy
+19,676
New +$1.29M 0.12% 176

Other funds holding CL

Meeder Asset Management's CL Position: Q1 2026 in Review

Meeder Asset Management increased its Colgate-Palmolive (CL) stake by 316% in Q1 2026, buying an estimated $37.7K and bringing the position to 557 shares worth $47.5K. The position accounts for ﹤0.01% of the portfolio, ranked #455.

Meeder Asset Management first reported a position in CL in Q3 2015 and has held it in 30 quarters since. The position peaked at $4.56M in Q4 2017. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Meeder Asset Management held 557 shares of Colgate-Palmolive worth $47.5K as of Q1 2026.
  • Meeder Asset Management bought 423 Colgate-Palmolive shares in Q1 2026, an estimated $37.7K.
  • Colgate-Palmolive made up ﹤0.01% of Meeder Asset Management's portfolio in Q1 2026, its #455 holding.
  • Meeder Asset Management first reported a position in Colgate-Palmolive in Q3 2015 and has held it in 30 quarters since.
  • Meeder Asset Management's Colgate-Palmolive position peaked at $4.56M in Q4 2017.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.